Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,500 public trials 2,843 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Disseminated Intravascular Coagulation (DIC) Score and Organ Dysfunction in Septic Shock Patients

NCT06363149

Conditions: Blood Coagulation Disorders, Critical Illness, Disease Attributes, +15 more
Locations: Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow, Uttar Pradesh, India

View Trial Details

Completed

A Study Using Real-world Data to Examine Outcomes in Children and Adults Who Develop a Blood Clotting Disorder Called Thrombotic Microangiopathy (TMA) After Undergoing a Hematopoietic Stem Cell Transplant (HSCT).

NCT07732361

Conditions: Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +5 more
Locations: Research Facility Boston, Massachusetts, United States

Research Facility Akron, Ohio, United States

Research Facility Salt Lake City, Utah, United States

Research Facility Brussels, Brussels Capital, Belgium

View all 43 locations

View Trial Details

Completed

Modifiers of Disease Severity in Cerebral Cavernous Malformations

NCT01764529

Conditions: Brain Diseases, Cardiovascular Abnormalities, Cardiovascular Diseases, +22 more
Locations: Barrow Neurological Institute Phoenix, Arizona, United States

University of California, San Francisco San Francisco, California, United States

University of Chicago, Medicine and Biological Sciences Chicago, Illinois, United States

Boston Children's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy

NCT04975555

Conditions: Acute Lymphoblastic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +26 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy

NCT06657183

Conditions: Agranulocytosis, Cytopenia, Febrile Neutropenia, +5 more
Locations: Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Rehabilitation Management for Patients With Multiple Myeloma

NCT06838065

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: AUSL-IRCCS of Reggio EmiliaOperational Unit of Physical Medicine and Rehabilitation AUSL - IRCCS Reggio Emilia, Reggio Emilia, Emilia Romagna 42123 Reggio Emilia, Italy

View Trial Details

Completed

Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome

NCT03672539

Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Bone Marrow Diseases, Chronic Disease, +18 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia

NCT03836209

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

University of California, San Francisco-Fresno (University Oncology Associates) Clovis, California, United States

UCLA Los Angeles, California, United States

Kaiser Permanente Oakland Oakland, California, United States

View all 44 locations

View Trial Details

Completed

2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies

NCT03712878

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +3 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy

NCT06399289

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: Beijing Children's Hospital Beijing, Beijing Municipality, China

Union Hospital Affiliated to Fujian Medical University Fuzhou, Fujian, China

Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China

Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions